Verseon is a drug discovery company founded in 2002. Our proprietary drug design platform identifies novel potential therapeutics faster and more inexpensively than conventional methods. The company ...
Verseon is a drug discovery company founded in 2002. Our proprietary drug design platform identifies novel potential therapeutics faster and more inexpensively than conventional methods. The company plans to use its platform to establish a diversified discovery pipeline across multiple disease areas. Current drug programs include cardiovascular diseases, macular degeneration, and oncology.